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OBJECTIVES We sought to determine the effect of diabetes mellitus (DM) on left ventricular (LV) filling
pattern in normotensive (NT) and hypertensive (HTN) individuals.
BACKGROUND Diastolic abnormalities have been extensively described in HTN but are less well character-
ized in DM, which frequently coexists with HTN.
METHODS We analyzed the transmitral inflow velocity profile at the mitral annulus in four groups from
the Strong Heart Study: NT-non-DM (n 5 730), HTN-non-DM (n 5 394), NT-DM (n 5
616) and HTN-DM (n 5 671). The DM subjects were further divided into those with
normal filling pattern (n 5 107) and those with abnormal relaxation (AbnREL) (n 5 447).
RESULTS The peak E velocity was lowest in HTN-DM, intermediate in NT-DM and HT-non-DM
and highest in the NT-non-DM group (p , 0.001), with a reverse trend seen for peak A
velocity (p , 0.001). In multivariate analysis, E/A ratio was lowest in HTN-DM and highest
in NT-non-DM, with no difference between NT-DM and HTN-non DM (p , 0.001).
Likewise, mean atrial filling fraction and deceleration time were highest in HTN-DM,
followed by HTN-non-DM or NT-DM and lowest in NT-non-DM (both p , 0.05).
Among DM subjects, those with AbnREL had higher fasting glucose (p 5 0.03) and
hemoglobin A1C (p 5 0.04).
CONCLUSIONS Diabetes mellitus, especially with worse glycemic control, is independently associated with
abnormal LV relaxation. The severity of abnormal LV relaxation is similar to the well-known
impaired relaxation associated with HTN. The combination of DM and HTN has more
severe abnormal LV relaxation than groups with either condition alone. In addition,
AbnREL in DM is associated with worse glycemic control. (J Am Coll Cardiol 2001;37:
1943–9) © 2001 by the American College of Cardiology
Diabetes mellitus (DM) is an established risk factor for
cardiovascular events (1,2), especially the development of
congestive heart failure (3). It has been suggested that
impairment of left ventricular (LV) function in patients
with DM is due to concomitant risk factors such as arterial
hypertension (HTN) or to diffuse peripheral and coronary
atherosclerosis (4,5). However, actual mechanisms remain
unclear and evidence has accumulated for the existence of a
distinct diabetic cardiomyopathy (6).
Impairment of LV diastole in patients with DM filling
has been described using digitized M-mode and Doppler
echocardiography (7,8). However, previous reports of the
association of diastolic abnormalities with DM did not take
into account confounding factors such as HTN, increased
LV mass and abnormal systolic function, which frequently
coexist with DM (9–11). Furthermore, the relationship of
glucose control to LV diastolic filling in DM has not been
well defined. The present study was undertaken to deter-
mine the effect of DM on LV filling in normotensive and
hypertensive adults using Doppler transmitral flow velocity
profile, and to assess the relationship of glycemic control to
diastolic function in the DM population.
METHODS
The Strong Heart Study (SHS) is a population-based survey
of cardiovascular risk factors and prevalent and incident
cardiovascular disease in American Indian communities in
Arizona, Oklahoma and South and North Dakota. The
study was conducted by the University of Oklahoma with
approval by the institutional committee on human research,
the Indian Health Service and the tribe and was performed
with the subjects’ written informed consent. As previously
described (12–14), tribal members aged 45 to 74 years from
three tribes in Arizona, seven tribes in southwestern Okla-
homa and three communities in North/South Dakota were
recruited from tribal members living on reservations or (in
Oklahoma) in a defined geographic area (overall participa-
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tion rate 62%) for an initial examination in from 1989 to
1992.
The second SHS examination was conducted from 1993
to 1995 to assess change over time in body habitus, blood
pressure and most other baseline measures and to add
echocardiography among surviving participants. A total of
3,630 surviving cohort members participated in the second
SHS examinations, for an 89% return rate. Standardized
measurements of seated brachial blood pressure; aspects of
body habitus including body mass index, waist, hip ratio and
percent body fat by bioelectric impedance; fasting glucose,
insulin, lipid and lipoprotein concentrations; and 2-h glu-
cose tolerance test and glycosylated hemoglobin levels were
obtained. Diabetes was diagnosed by World Health Orga-
nization criteria (15) if fasting blood sugar was .140 mg/dl,
2-h post challenge glucose was .200 mg/dl or participants
received hypoglycemic medication. Individuals with fasting
sugar levels ,140 mg/dl were divided into those with
normal or impaired glucose tolerance depending on whether
2-h post-challenge glucose was , or $200 mg/dl. Duration
of diabetes was based on patient reports. Participants were
classified as hypertensive if blood pressure was $140 and/or
90 mm Hg or if participants were on antihypertensive drugs.
Echocardiograms were performed in 3,501 participants
(97%) in the second SHS examination. For the present
study, SHS participants with normal glucose tolerance were
compared with those with diabetes; individuals with im-
paired glucose tolerance were excluded to maximize the
contrast between groups. Echocardiographic readers were
blinded to participant clinical status.
Eligible participants in the second SHS examination were
divided into four nonoverlapping groups: 1) 730 participants
with neither hypertension nor diabetes (NT-non-DM); 2)
616 normotensive individuals with diabetes (NT-DM); 3)
394 hypertensive individuals without DM (HTN-non-
DM); and 4) 671 hypertensive individuals with DM (HTN-
DM). For some analyses, the DM subjects were further
divided on the basis of diastolic filling pattern: normal filling
pattern (E/A $1 and ,2.0 and deceleration time [DT]
$160 and ,240 ms); abnormal relaxation (E/A, 1 and
DT $240 ms); restrictive filling pattern (E/A .2 and DT
,160 ms). Exclusion of individuals with prior definite
myocardial infarction or coronary heart disease or segmental
akinesis or dyskinesis did not affect study results. Subjects
with ejection fraction ,55% were excluded, as were those
with suboptimal echocardiograms for LV mass or transmi-
tral Doppler measurements, or with .21 mitral or aortic
regurgitation.
Echocardiographic methods. Imaging and Doppler echo-
cardiograms were performed using methods adapted from
those employed in previous studies from the New York
Presbyterian Hospital-Weill Cornell Medical Center echo-
cardiography reading center. As previously described
(16,17), studies were performed using phased-array echo-
cardiographs with M-mode, two-dimensional, and pulsed
continuous wave and color-flow Doppler capabilities. A
standardized protocol was followed under which needed
images and Doppler flow patterns were recorded $10
consecutive beats from appropriate acoustic windows
(16,17).
Echocardiographic measurements. Correct orientation of
planes for imaging and Doppler recordings was verified as
previously described (18). Measurements were made using a
computerized review station equipped with digitizing tablet
and monitor screen overlay for calibration and performance
of each needed measurement. Left ventricular internal
dimension and septal and posterior wall thicknesses were
measured by American Society of Echocardiography recom-
mendations (19) during up to three cardiac cycles. When
optimal orientation of LV M-mode recordings could not be
obtained, correctly oriented linear dimension measurements
were made using two-dimensional imaging by the American
Society of Echocardiography leading-edge convention (20).
To facilitate relating measurements of LV diastolic trans-
mitral blood flow velocity to volume flow, the pulsed
Doppler sample volume was placed at the middle of the
mitral annulus, the diameter of which varies relatively
modestly during the cardiac cycle, as opposed to the level of
the leaflet tips where the mitral orifice shows substantial
variation through the cardiac cycle. Participants were asked
to hold their breath during pulse-wave Doppler interroga-
tion. The leading edge of the transmitral Doppler flow
pattern was traced to derive the peak of early diastolic and
atrial-phase LV filling (E and A, respectively), their ratio,
the deceleration time of early diastolic LV filling and the
atrial filling fraction. Doppler measurements were per-
formed offline from an average of several cardiac cycles.
Heart rate was measured simultaneously.
Calculation of derived variable. End-diastolic LV dimen-
sions by the leading-edge convention were used to calculate
LV mass by an adjusted cube-function formula that yields
values closely correlated with necropsy LV weight (r 5 0.90,
p , 0.001) (21) and that showed good reproducibility
(RHO 5 0.93, p , 0.001) in a series of 183 hypertensive
patients studied twice by echocardiography (22). Left ven-
tricular mass measurements by this formula for M-mode or
two-dimensional measurements have been shown in a series
of 196 normotensive or hypertensive adults to be virtually
interchangeable (r 5 0.967, p , 0.001; mean difference 5
0.4 6 10.2 g, p 5 NS) (23). Left ventricular mass was
Abbreviations and Acronyms
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normalized for body height2.7, where 2.7 is the power of the
allometric or growth relation between LV mass and body
height (24).
Measures of myocardial performance. The primary ap-
proach to assess myocardial contractile efficiency was exam-
ination of LV systolic shortening in relation to end-systolic
stress. Because the traditional practice of relating endocar-
dial shortening to mean end-systolic stress across the LV
wall may yield misleading results in individuals with either
concentric geometry (25) or LV dilation (26), primary
reliance was placed on the relation of midwall fractional
shortening to midwall circumferential end-systolic stress
measured at the level of the LV minor axis (25,27,28).
Midwall shortening was calculated taking into account the
epicardial migration of the midwall during systole. Circum-
ferential end-systolic stress (cESS) was estimated at the
midwall from M-mode tracings, using a cylindrical model
(28). Observed midwall shortening was expressed as a
percentage of the value predicted from cESS using equa-
tions derived from previously studied normal subjects (25).
For convenience this variable is termed stress-corrected
midwall shortening (23).
Statistical analyses. Data were analyzed using SPSS 8.0
software (SPSS, Chicago, Illinois). Data are expressed as
mean 6 standard deviation. Differences between groups of
participants were assessed by analysis of variance followed
by the Scheffe´ post hoc test. Independence of differences
from effects of covariates was assessed by single-factorial
analysis of variance in the general linear model with Sidak’s
post hoc test. A two-tailed p , 0.05 indicated statistical
significance.
RESULTS
Characteristics of participants (Table 1). The NT-
non-DM participants were on average in late middle age,
with normal mean heart rate and blood pressure. Compared
with this reference group, HTN-non-DM participants were
older, had similar heart rate and, partially by definition,
higher systolic blood pressure (SBP). NT-DM participants
were similar in age to the reference group but had higher
heart rate and SBP. HTN-DM participants were older and
had higher heart rate than the reference group. In addition,
this group had higher SBP than the HTN-non-DM group.
Fifty-nine percent of the HTN-non-DM group and 72% of
the HTN-DM group were on antihypertensive treatment.
The HTN-DM group had the highest mean LV mass
and LV mass/height2.7. The NT-DM group had higher
mean LV mass and LV mass/height2.7 than the NT-
non-DM group. However, LV mass and LV mass/height2.7
were higher in the HTN-non-DM than in the NT-DM
group. Stress-corrected LV midwall shortening was lower in
the groups with DM than in the NT-non-DM and HTN-
non-DM groups.
Diastolic filling parameters (Table 2). Peak E velocity
was lower in both NT-DM and HTN-DM groups than the
NT-non-DM or HTN-non-DM groups. Peak A velocity
was higher in the NT-DM group than the NT-non-DM
group, but similar to the HTN-non-DM group and highest
in the HTN-DM group. The E/A ratio showed a stepwise
decrease from the NT-non-DM group to those with either
condition to the combined HTN-DM group. The deceler-
ation time of early diastolic transmitral flow was longer than
in the NT-non-DM group by a mean of about 10 ms in the
groups with either DM or HTN and by about 20 ms in the
HTN-DM group. In addition, atrial filling fraction and
first-half filling fraction were similar in the NT-DM and
the HTN-non-DM groups, whereas the DM-HTN group
had higher mean atrial filling fraction and lower mean
first-half filling fraction than the other groups. To avoid
underestimating the impact of hypertension and excessive
load on diastolic filling parameters due to vasodilator
therapy, a subanalysis was performed excluding participants
on antihypertensive treatment. The results remained un-
changed.
Table 1. Clinical Variables in Groups Defined by the Presence or Absence of Hypertension
or Diabetes
No HTN or DM
n 5 730
HTN only
n 5 394
DM only
n 5 616
HTN 1 DM
n 5 671
Female (%) 61* 59* 75†‡ 72†‡
Age (yr) 58 6 7‡ 61 6 8†‡ 58 6 7‡ 61 6 8†‡
Heart rate (beats/min) 66 6 10* 66 6 10* 69 6 10†‡ 69 6 10†‡
Systolic blood pressure
(mm Hg)
117 6 12* 140 6 19 120 6 11† 143 6 2*†
Diastolic blood pressure
(mm Hg)
71 6 8 80 6 11 71 6 8 78 6 11
HTN Rx (%) 0% 59% 0% 72%
LV mass (g) 145 6 32‡ 159 6 35*† 148 6 31‡ 161 6 37*†
LV mass index (g/m2.7) 37 6 8*‡ 42 6 9*† 40 6 8†‡ 44 6 10*†‡
Stress-corrected midwall
shortening (%)
108 6 10*‡ 110 6 10*† 105 6 11†‡ 106 6 11†‡
*p , 0.05 compared to DM by ANOVA followed by the Scheffe´ post-hoc test; †p , 0.05 compared to no HTN or DM by
ANOVA followed by the Scheffe´ post-hoc test; ‡p , 0.05 compared to HTN by ANOVA followed by the Scheffe´ post-hoc
test.
DM 5 diabetes mellitus; HTN 5 hypertension; LV 5 left ventricular; Rx 5 treatment.
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In analyses of covariance adjusting for age, gender, heart
rate, LV mass and stress-corrected midwall shortening
(Table 3), the mean E velocity was significantly lower in the
groups with DM than in the NT-non-DM group. Mean A
velocity was higher in groups with DM and/or HTN than
in the reference group. As a result, the E/A ratio decreased
stepwise from the NT-non-DM group to those with DM or
HTN alone to lowest values in the group with both
conditions. The deceleration time was longer in the DM- or
HTN-alone groups than in the NT-non-DM group and
was longest in the group with both conditions. Mean atrial
filling fraction was slightly higher and the mean first-half
filling fraction slightly lower in the NT-DM group than in
the HTN-non-DM and NT-non-DM groups; both vari-
ables were, on average, more abnormal in the HTN-DM
group.
Indices of DM control and diastolic filling. Among the
DM group, 330 participants had abnormal LV relaxation
(E/A ,1 and DT $240 ms) and 89 participants had normal
filling pattern (1 # E/A , 2 and 160 ms # DT , 240 ms).
The restrictive filling group was excluded from the analysis
because of its small size (only seven DM subjects with E/A
.2 and DT ,160 ms). In multivariate analyses adjusting
for age, heart rate, LV mass and stress-corrected midwall
shortening, the abnormal relaxation group had higher fast-
ing glucose, higher hemoglobin A1C levels and a trend
towards longer reported duration of DM (Table 4). There
was no difference in insulin levels. In addition, the abnormal
relaxation group had a significantly higher urinary albumin/
creatinine ratio.
DISCUSSION
The present study represents the first comprehensive assess-
ment of LV diastolic filling in adults with Type II DM in a
population-based sample of middle-aged and older adults.
The present study reveals an association between DM and
abnormal early diastolic filling that is independent of age,
arterial pressure, LV mass and systolic function. This
association, as seen in the NT-DM group, is at least as
strong as the well-known one of HTN with impaired early
diastolic LV relaxation and filling. Concomitant DM fur-
ther adds to the impairment of LV relaxation associated
with HTN, as demonstrated by the finding that SHS
participants with both DM and HTN had the most severely
abnormal LV filling. Excluding the large percentage of the
HTN groups who were on treatment in a subanalysis did
not alter the results.
Diastolic LV filling patterns. In our study of a
population-based sample with a high prevalence of type 2
DM, the peak E velocity of early LV filling was lower in the
NT-DM-alone group than in the reference group and
lowest in the group with both conditions, independent of
age, heart rate, LV mass and systolic function. Likewise, the
ratios of early filling to atrial-augmented LV filling showed
a stepwise decline from the NT-non-DM group to those
with DM or HTN alone to the group with both DM and
HTN. Parallel to these findings, previous studies have
demonstrated a shift in LV filling from early relaxation
phase to the late atrial phase in young type 1 diabetics
(8,29–31).
Table 2. Diastolic Filling Parameters in Groups Defined by the Presence or Absence of
Hypertension or Diabetes
Variable
No HTN or DM
n 5 719
HTN
n 5 390
DM
n 5 602
HTN 1 DM
656
E velocity (cm/s) 61 6 18* 59 6 16* 57 6 16†‡ 56 6 17†‡
A velocity (cm/s) 68 6 15*‡ 73 6 17† 71 6 15† 76 6 16*†
E/A ratio 0.92 6 0.27*‡ 0.83 6 0.23† 0.83 6 0.24† 0.76 6 0.22*†‡
Deceleration time (ms) 195 6 59‡ 204 6 66† 202 6 64 215 6 71*†‡
Atrial filling fraction 0.38 6 0.08* 0.40 6 0.09† 0.40 6 0.08† 0.42 6 0.10†‡
First-half filling fraction 0.53 6 0.07*‡ 0.51 6 0.07† 0.50 6 0.08† 0.49 6 0.08*†‡
*p , 0.05 compared to DM by ANOVA followed by the Scheffe´ post-hoc test; †p , 0.05 compared to no HTN or DM by
ANOVA followed by the Scheffe´ post-hoc test; ‡p , 0.05 compared to HTN by ANOVA followed by the Scheffe´ post-hoc
test.
DM 5 diabetes mellitus; HTN 5 hypertension.
Table 3. Diastolic Filling Parameters in Groups Defined by the Presence or Absence of Hypertension or Diabetes*
Variable
No HTN or
DM (adjusted
mean 6 SD)
HTN (adjusted
mean 6 SD)
DM (adjusted
mean 6 SD)
HTN 1 DM
(adjusted
mean 6 SD)
E velocity (cm/s) 59.9 6 0.6† 59.0 6 0.8 57.4 6 0.7‡ 57.5 6 0.7‡
A velocity (cm/s) 67.5 6 5.1§ 72.6 6 5.3‡ 70.7 6 4.9 74.4 6 5.1†‡§
E/A ratio 0.891 6 0.008†§ 0.834 6 0.011‡ 0.828 6 0.009‡ 0.788 6 0.009†‡§
Deceleration time (s) 197.2 6 2.5 203.0 6 3.3 201.7 6 2.7 212.4 6 2.6†‡§
Atrial filling fraction 0.389 6 0.025†§ 0.398 6 0.004†‡ 0.404 6 0.003‡§ 0.412 6 0.003†‡§
First-half filling fraction 0.53 6 0.08†§ 0.51 6 0.07‡ 0.50 6 0.08‡ 0.49 6 0.08†‡§
*Adjusted for covariates: age, heart rate, LV mass, stress-corrected midwall shortening; †p , 0.05 compared to DM by ANOVA followed by the Sidak post-hoc test; ‡p , 0.05
compared to no HTN or DM by ANOVA followed by the Sidak post-hoc test; §p , 0.05 compared to HTN by ANOVA followed by the Sidak post-hoc test.
DM 5 diabetes mellitus; HTN 5 hypertension; LV 5 left ventricular.
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Although the peak A velocity was higher in the group
with HTN alone than in that with DM alone, the atrial
filling fraction, which is less afterload-dependent, was
higher in the DM-only group than in the HTN-only group
or the reference group. Both peak A velocity and atrial
filling fraction were highest in the combined HTN and DM
group.
Diabetes and abnormal LV diastolic relaxation. The
association of diastolic filling abnormalities with DM in
adults has been previously reported (7,32–34). However, our
study is the first to confirm that this association is indepen-
dent of other confounding variables that frequently coexist
with DM. The abnormality of relaxation was more severe in
the combined DM-HTN group than in the HTN-
non-DM or NT-DM groups, suggesting additive deleteri-
ous effects on active LV relaxation in early diastole when
both of these conditions are present.
Our study revealed that DM participants with abnormal
LV diastolic filling had worse glycemic control as indicated
by higher levels of hemoglobin A1C and fasting glucose
than DM individuals with normal LV diastolic filling. Our
findings complement previous observations of abnormal late
diastolic LV compliance in DM. Jain et al. (32) found that
greater fasting hyperglycemia in hypertensive patients cor-
related with increased myocardial stiffness. Experimental
evidence in dogs with alloxan-induced DM suggests that
myocardial glycoprotein deposition can impair the LV
end-diastolic pressure/volume ratio in the absence of hyper-
tension (35). Of note, higher plasma insulin level was not
found to be associated with apparent abnormal LV relax-
ation, extending previous evidence that diastolic stiffness
was not related to plasma insulin (36).
Potential pathogenesis. The observation that indices of
poor glycemic control were associated with abnormal LV
diastolic filling in the DM population suggests that hyper-
glycemia may contribute to the pathogenetic mechanism of
abnormal ventricular relaxation in DM. Interstitial accumu-
lation of advanced-glycated end products (AGES), which
include collagen, elastin and other connective tissue pro-
teins, as well as fibrosis in the myocardium have been
reported in human diabetic hearts (37,38), which can
increase end-diastolic stiffness as well as LV mass. Quanti-
tation of fibrosis in hypertensive, diabetic and hypertensive-
diabetic hearts has revealed the lowest proportions in
hypertensive hearts and the highest in hypertensive-diabetic
hearts, with diabetic hearts in the midrange (37). Greater
myocardial fibrosis and AGES in diabetic hearts than in
hypertensive hearts parallel but, because of their greater
effect on late diastolic than on early diastolic filling param-
eters, do not directly explain the similar abnormal relaxation
seen in the DM-alone and HTN-alone groups. In addition,
abnormal relaxation in subjects with DM was also associ-
ated in our study with renal microvascular disease and a
trend toward arterial stiffening, which supports a systemic
process in which parallel nonenzymatic production of
AGES may occur in myocardium, arterioles and capacitance
arteries in diabetics. Our study also showed that longer
duration of DM is positively related to abnormal LV
relaxation.
Another factor linking DM and abnormal LV relaxation
may be the presence of coronary artery disease. Although
that may be the etiology in some cases, the majority of our
subjects had normal wall motion with ejection fraction
$55%. In addition, when the analyses were repeated,
excluding those with a history of coronary artery disease, the
results remained unchanged. This finding is supported by
similar reports of impaired early diastolic LV filling in
asymptomatic children with DM without confounding
coronary disease, obesity or hypertension (31).
Clinical implications. This study confirms and substan-
tially extends previous findings by revealing additional
cardiovascular abnormalities associated with DM. Diabetes
mellitus is associated with abnormal LV relaxation, similar
to the well-known impaired relaxation associated with
HTN. Abnormal LV relaxation seen in DM, independent
of other factors, may contribute to the incidence of conges-
tive heart failure despite normal LV ejection fraction,
thereby being another cause of clinical cardiovascular mor-
bidity. In addition, reduced mitral E/A ratio is indepen-
dently associated with increased all-cause mortality as well
as cardiovascular mortality (39). Abnormal LV filling pat-
tern may be an early functional alteration of the left ventricle
preceding systolic dysfunction. Furthermore, the association
of worse glycemic control and abnormal LV filling pattern
suggests that degree of hyperglycemia may play a role in the
pathogenesis of diastolic dysfunction in DM. A prospective
trial is needed to determine whether better glycemic control
will improve LV structure and function in adults with type
II DM.
Study limitations. Doppler measurements of mitral inflow
were made at the mitral annulus instead of the mitral tip,
which is recommended by most consensus statements.
However, the same methodology was used in all groups, and
we have previously reported strong correlation between LV
inflow measurement at the levels of the annulus and leaflet
tips (40). Because of lack of recordings of pulmonary vein
flow or mitral inflow responses to preload reduction, pre-
cluded by the need to limit echocardiogram performance
Table 4. Indices of Diabetes Control and LV Diastolic Filling
in the Diabetic Population
Normal
Filling*
n 5 89
Abnormal
Relaxation*
n 5 330
p
Value
Fasting glucose mg/dl 172 6 84 206 6 76 0.002
Insulin mU/ml 27 6 28 28 6 30 NS
HbA1C % 7.8 6 2.8 8.5 6 1.8 0.01
Log urinary albumin/
creatinine
3.6 6 1.9 4.3 6 2.2 0.01
Pulse pressure/stroke volume 0.83 6 0.30 0.85 6 0.18 NS
Duration of DM (yrs) 9.3 6 10.3 11.2 6 10.9 NS
*Adjusted mean 6 standard deviation.
DM 5 diabetes mellitus.
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time to 30 min or less, the “pseudonormalized” pattern
cannot be differentiated from the true “normal” group.
However, given that the population had relatively normal
LV mass and normal systolic function, it is unlikely that
many of our patients were pseudonormalized. The cross-
sectional nature of the study limits its ability to establish
causality and, thus, mechanism of the cardiovascular abnor-
malities associated with DM. A prospective intervention
study is needed to determine the reversibility and effective-
ness of treatment (i.e., glycemic and/or blood pressure
control), as well as elucidating the mechanism of the adverse
cardiovascular features associated with DM. The study was
performed in the American Indian population, and whether
the results can be generalized to other ethnic groups requires
further study.
CONCLUSIONS
Diabetes mellitus is independently associated with abnormal
LV relaxation pattern of Doppler transmitral flow velocity
profiles, similar in degree to the well-known impaired
relaxation associated with HTN. Abnormal LV relaxation is
most severe in participants with both HTN and DM.
Abnormal relaxation in individuals with DM is associated
with worse glycemic control.
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